IBEX Innovations Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 28
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $4.58M
Latest Deal Amount
  • Investors
  • 8

IBEX Innovations General Information

Description

Developer of x-ray imaging technology designed to improve the contrast and resolution available from silicon-based complementary metal-oxide-semiconductor (CMOS) and flat-panel detectors. The company's technology generates sensitive material information from standard x-ray detectors and transforms medical X-ray imaging by extracting the maximum amount of diagnostic value from every X-ray scan, enabling healthcare providers to deliver improved medical diagnostic imaging as well as detection of impurities, defects, and threats.

Contact Information

Formerly Known As
Eshtech Limited
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • Explorer 2, NETPark
  • Thomas Wright Way
  • Sedgefield TS21 3FF
  • England, United Kingdom
+44 01740 000000

IBEX Innovations Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IBEX Innovations Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 02-Jun-2021 $4.58M 000.00 000.00 Completed Generating Revenue
11. Later Stage VC 15-May-2020 00000 00.000 00.000 Completed Generating Revenue
10. Secondary Transaction - Private 00.000 Completed Generating Revenue
9. Later Stage VC 20-Mar-2019 00.000 00.000 00.00 Completed Generating Revenue
8. Later Stage VC 26-Nov-2018 00.000 00.000 00.000 Completed Generating Revenue
7. Grant 18-May-2017 00.000 00.000 Completed Generating Revenue
6. Grant 25-Jan-2016 00000 00.000 Completed Generating Revenue
5. Grant 18-Mar-2015 00000 00.000 Completed Generating Revenue
4. Early Stage VC 06-Oct-2014 $3.14M $4.73M 000.00 Completed Generating Revenue
3. Grant 30-Sep-2013 $397K $1.59M Completed Generating Revenue
To view IBEX Innovations’s complete valuation and funding history, request access »

IBEX Innovations Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 705,830 $0.000014 $3.86 $3.86 1x $3.86 14.86%
Ordinary 592,449 $0.000014 $2.48 $2.48 1x $2.48 12.48%
To view IBEX Innovations’s complete cap table history, request access »

IBEX Innovations Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of x-ray imaging technology designed to improve the contrast and resolution available from silicon-based compl
Other Healthcare Technology Systems
Sedgefield, United Kingdom
28 As of 2022
000.00
00.00 0000-00-00
0000000000 0 000.00

000000 0

ugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia dese
0000000000 000000000 000 00000000000
Sedgefield, United Kingdom
000 As of 0000
00000
000 0000-00-00
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IBEX Innovations Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 00000 Formerly VC-backed Sedgefield, United Kingdom 000 00000 000000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

IBEX Innovations Patents

IBEX Innovations Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202007725-D0 Composition-guided post processing for x-ray images Pending 06-Dec-2019 00000000
GB-2590519-A Composition-guided post processing for x-ray images Pending 06-Dec-2019 00000000 0
GB-2589643-A Material-based x-ray image enhancement Pending 06-Dec-2019 00000000
GB-2589643-A8 Material-based x-ray image enhancement Pending 06-Dec-2019 00000000
GB-201917920-D0 Material-based x-ray image enhancement Pending 06-Dec-2019 G06T5/00
To view IBEX Innovations’s complete patent history, request access »

IBEX Innovations Executive Team (3)

Name Title Board Seat Contact Info
Neil Loxley Ph.D Chief Executive Officer & Board Member
Paul Scott Chief Technology Officer & Board Member
Gary Gibson Ph.D Founder & Board Member
To view IBEX Innovations’s complete executive team members history, request access »

IBEX Innovations Board Members (8)

Name Representing Role Since
Alastair Stewart IP Group Board Member 000 0000
Charles Holroyd Self Chairman 000 0000
Gary Gibson Ph.D IBEX Innovations Founder & Board Member 000 0000
Neil Loxley Ph.D IBEX Innovations Chief Executive Officer & Board Member 000 0000
Paul Scott IBEX Innovations Chief Technology Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

IBEX Innovations Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IBEX Innovations Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
North East Fund Venture Capital Minority 000 0000 000000 0
European Regional Development Fund (Brandenburg) Sovereign Wealth Fund Minority 000 0000 000000 0
Mercia Asset Management Venture Capital Minority 000 0000 000000 0
Horizon 2020 SME Instrument Government 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »